Suppr超能文献

去 PAR 化在 DNA 损伤修复和癌症抑制中的作用。

The role of dePARylation in DNA damage repair and cancer suppression.

机构信息

Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010, USA.

Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010, USA.

出版信息

DNA Repair (Amst). 2019 Apr;76:20-29. doi: 10.1016/j.dnarep.2019.02.002. Epub 2019 Feb 8.

Abstract

Poly(ADP-ribosyl)ation (PARylation) is a reversible post-translational modification regulating various biological pathways including DNA damage repair (DDR). Rapid turnover of PARylation is critically important for an optimal DNA damage response and maintaining genomic stability. Recent studies show that PARylation is tightly regulated by a group of enzymes that can erase the ADP-ribose (ADPR) groups from target proteins. The aim of this review is to present a comprehensive understanding of dePARylation enzymes, their substrates and roles in DDR. Special attention will be laid on the role of these proteins in the development of cancer and their feasibility in anticancer therapeutics.

摘要

聚(ADP-核糖)化(PARylation)是一种可逆的翻译后修饰,调节包括 DNA 损伤修复(DDR)在内的多种生物途径。PARylation 的快速转换对于最佳的 DNA 损伤反应和维持基因组稳定性至关重要。最近的研究表明,PARylation 受到一组可以从靶蛋白上去除 ADP-核糖(ADPR)基团的酶的严格调控。本综述旨在全面了解去 PARylation 酶、其底物以及它们在 DDR 中的作用。特别关注这些蛋白质在癌症发展中的作用及其在抗癌治疗中的可行性。

相似文献

1
The role of dePARylation in DNA damage repair and cancer suppression.
DNA Repair (Amst). 2019 Apr;76:20-29. doi: 10.1016/j.dnarep.2019.02.002. Epub 2019 Feb 8.
2
Functions of PARylation in DNA Damage Repair Pathways.
Genomics Proteomics Bioinformatics. 2016 Jun;14(3):131-139. doi: 10.1016/j.gpb.2016.05.001. Epub 2016 May 27.
3
Poly-ADP ribosylation in DNA damage response and cancer therapy.
Mutat Res Rev Mutat Res. 2019 Apr-Jun;780:82-91. doi: 10.1016/j.mrrev.2017.09.004. Epub 2017 Sep 20.
4
Poly(ADP-ribose): PARadigms and PARadoxes.
Mol Aspects Med. 2013 Dec;34(6):1046-65. doi: 10.1016/j.mam.2012.12.010. Epub 2013 Jan 2.
5
Poly(ADP-ribosyl)ation in carcinogenesis.
Mol Aspects Med. 2013 Dec;34(6):1202-16. doi: 10.1016/j.mam.2013.05.003. Epub 2013 May 25.
6
DNA maintenance following bleomycin-induced strand breaks does not require poly(ADP-ribosyl)ation activation in Drosophila S2 cells.
DNA Repair (Amst). 2016 Dec;48:8-16. doi: 10.1016/j.dnarep.2016.10.002. Epub 2016 Oct 21.
7
Poly(ADP-ribose) protects vascular smooth muscle cells from oxidative DNA damage.
BMB Rep. 2015 Jun;48(6):354-9. doi: 10.5483/bmbrep.2015.48.6.012.
8
Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
Nucleic Acids Res. 2019 May 7;47(8):3811-3827. doi: 10.1093/nar/gkz120.
9
10
Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
Methods Mol Biol. 2018;1813:91-108. doi: 10.1007/978-1-4939-8588-3_7.

引用本文的文献

2
PARG inhibitor sensitivity correlates with accumulation of single-stranded DNA gaps in preclinical models of ovarian cancer.
Proc Natl Acad Sci U S A. 2024 Nov 19;121(47):e2413954121. doi: 10.1073/pnas.2413954121. Epub 2024 Nov 15.
3
Truncated PARP1 mediates ADP-ribosylation of RNA polymerase III for apoptosis.
Cell Discov. 2022 Jan 18;8(1):3. doi: 10.1038/s41421-021-00355-1.
5
ADP-ribosylhydrolases: from DNA damage repair to COVID-19.
J Zhejiang Univ Sci B. 2021 Jan 15;22(1):21-30. doi: 10.1631/jzus.B2000319.
6
AI26 inhibits the ADP-ribosylhydrolase ARH3 and suppresses DNA damage repair.
J Biol Chem. 2020 Oct 2;295(40):13838-13849. doi: 10.1074/jbc.RA120.012801. Epub 2020 Aug 4.
7
Molecular basis for the MacroD1-mediated hydrolysis of ADP-ribosylation.
DNA Repair (Amst). 2020 Oct;94:102899. doi: 10.1016/j.dnarep.2020.102899. Epub 2020 Jun 22.
8
Targeting dePARylation for cancer therapy.
Cell Biosci. 2020 Jan 29;10:7. doi: 10.1186/s13578-020-0375-y. eCollection 2020.
9
Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death.
Nat Commun. 2019 Dec 11;10(1):5654. doi: 10.1038/s41467-019-13508-4.

本文引用的文献

2
PARP2 mediates branched poly ADP-ribosylation in response to DNA damage.
Nat Commun. 2018 Aug 13;9(1):3233. doi: 10.1038/s41467-018-05588-5.
3
Structure-function analyses reveal the mechanism of the ARH3-dependent hydrolysis of ADP-ribosylation.
J Biol Chem. 2018 Sep 14;293(37):14470-14480. doi: 10.1074/jbc.RA118.004284. Epub 2018 Jul 25.
4
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions.
Nature. 2018 Jul;559(7713):285-289. doi: 10.1038/s41586-018-0291-z. Epub 2018 Jul 4.
5
Synthetic lethal therapies for cancer: what's next after PARP inhibitors?
Nat Rev Clin Oncol. 2018 Sep;15(9):564-576. doi: 10.1038/s41571-018-0055-6.
6
High speed of fork progression induces DNA replication stress and genomic instability.
Nature. 2018 Jul;559(7713):279-284. doi: 10.1038/s41586-018-0261-5. Epub 2018 Jun 27.
8
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality.
Cancer Cell. 2018 Jun 11;33(6):1078-1093.e12. doi: 10.1016/j.ccell.2018.05.008.
9
Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal Tumors.
Cancer Discov. 2018 Aug;8(8):988-1005. doi: 10.1158/2159-8290.CD-17-0909. Epub 2018 Jun 7.
10
Destabilization of linker histone H1.2 is essential for ATM activation and DNA damage repair.
Cell Res. 2018 Jul;28(7):756-770. doi: 10.1038/s41422-018-0048-0. Epub 2018 May 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验